Timing of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor initiation and allograft vasculopathy progression and outcomes in heart transplant recipients-Reference-Cited by-同舟云学术

Timing of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor initiation and allograft vasculopathy progression and outcomes in heart transplant recipients

Published:2018-07-17 Issue:6 Volume:5 Page:1118-1129
ISSN:2055-5822
Container-title:ESC Heart Failure
language:en
Short-container-title:ESC Heart Failure

Author:

Asleh Rabea¹,Briasoulis Alexandros¹,Pereira Naveen L.¹,Boilson Barry A.¹,Edwards Brooks S.¹,Adigun Rosalyn¹,Maltais Simon¹,Daly Richard C.¹,Lerman Amir¹,Kushwaha Sudhir S.¹

Affiliation:

1. Department of Cardiovascular Diseases; Mayo Clinic; Rochester MN USA

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ehf2.12329/fullpdf

Reference33 articles.

1. The Registry of the International Society for Heart and Lung Transplantation: Thirty-second Official Adult Heart Transplantation Report--2015; Focus Theme: Early Graft Failure;Lund;J Heart Lung Transplant,2015

2. Donor age is associated with chronic allograft vasculopathy after adult heart transplantation: implications for donor allocation;Nagji;Ann Thorac Surg,2010

3. Allograft vasculopathy versus atherosclerosis;Rahmani;Circ Res,2006

4. Heart transplant coronary artery disease detected by coronary angiography: a multi-institutional study of preoperative donor and recipient risk factors;Costanzo;Cardiac Transplant Research Database J Heart Lung Transplant,1998

5. International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010;Mehra;J Heart Lung Transplant,2010

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipoprotein (a) and lipid-lowering treatment from the perspective of a cardiac surgeon. An impact on the prognosis in patients with aortic valve replacement and after heart transplantation;International Journal of Cardiology Cardiovascular Risk and Prevention;2024-09

2. Uncertain benefit of statins in pediatric heart transplant recipients: A PHTS analysis;The Journal of Heart and Lung Transplantation;2023-12

3. Cardiac Allograft Vasculopathy;Textbook of Transplantation and Mechanical Support for End‐Stage Heart and Lung Disease;2023-09-08

4. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines;Circulation;2023-08-29

5. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease;Journal of the American College of Cardiology;2023-08